Lung cancer targeted Raman active phospholipid gold nanoparticles for ultrasensitive and specific molecular imaging and detection

Natalie C. M. Tam; Benjamin M. T. Scott; Brian C. Wilson; Gang Zheng

doi:10.1117/12.889893

14 June 2011 Lung cancer targeted Raman active phospholipid gold nanoparticles for ultrasensitive and specific molecular imaging and detection

Natalie C. M. Tam, Benjamin M. T. Scott, Brian C. Wilson, Gang Zheng

Author Affiliations +

Proceedings Volume 8090, Novel Biophotonic Techniques and Applications; 80900A (2011) https://doi.org/10.1117/12.889893
Event: European Conferences on Biomedical Optics, 2011, Munich, Germany

Abstract

Lung cancer is the leading cause of cancer related mortalities. With current imaging modalities, non-invasive diagnosis of this deadly cancer is difficult due to the lack in specificity. Photonics based optical molecular imaging is a promising alternative for early lung cancer diagnosis because of its molecular based detection for specificity and relatively low cost instrumentation. In particular, gold nanoparticle-based surface enhanced Raman scattering (SERS) probes have shown great promise for disease detection and diagnosis because of its remarkable sensitivity and its ease of engineering for high specificity. Here, a stabilized, biocompatible SERS probe, Raman active phospholipid gold nanoparticles, is synthesized and conjugated to epidermal growth factor to target its receptor, epidermal growth factor receptor (EGFR), a common lung cancer biomarker. This novel nanoparticle encapsulates Raman molecules adsorbed on 60 nm colloidal gold with a phospholipid bilayer coating which show structural and functional stability in serum over 24 hours. Moreover, when conjugated with epidermal growth factor, it specifically detects and localizes EGFR on lung carcinoma cells. We used transmission electron microscopy, Raman and UV spectroscopy to validate the novel nanoparticle's reproducibility and stability. We also validated its molecular specificity and use it as an efficient contrast agent with in vitro confocal reflectance microscopy on lung carcinoma. This novel lipid-based SERS probe provides a viable alternative as a tool for detecting lung cancer biomarkers for non invasive, ultrasensitive and specific diagnoses.

Citation Download Citation

Natalie C. M. Tam, Benjamin M. T. Scott, Brian C. Wilson, and Gang Zheng "Lung cancer targeted Raman active phospholipid gold nanoparticles for ultrasensitive and specific molecular imaging and detection", Proc. SPIE 8090, Novel Biophotonic Techniques and Applications, 80900A (14 June 2011); https://doi.org/10.1117/12.889893

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available